[PHARMA] QoQ TTM Result on 30-Sep-2002 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Nov-2002
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2002
Quarter
30-Sep-2002 [#3]
Profit Trend
QoQ- 12.94%
YoY- 60.79%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
Revenue 596,928 599,086 585,237 594,966 578,889 553,176 543,496 6.46%
PBT 62,072 65,591 61,170 64,797 58,312 52,093 51,604 13.14%
Tax -23,185 -23,946 -23,829 -26,084 -24,033 -22,413 -20,800 7.52%
NP 38,887 41,645 37,341 38,713 34,279 29,680 30,804 16.85%
-
NP to SH 38,887 41,645 37,341 38,713 34,279 29,680 30,804 16.85%
-
Tax Rate 37.35% 36.51% 38.96% 40.25% 41.21% 43.02% 40.31% -
Total Cost 558,041 557,441 547,896 556,253 544,610 523,496 512,692 5.82%
-
Net Worth 194,744 192,761 179,444 172,829 159,457 167,817 160,519 13.79%
Dividend
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
Div 3,744 3,744 3,744 5,002 3,750 3,750 3,750 -0.10%
Div Payout % 9.63% 8.99% 10.03% 12.92% 10.94% 12.64% 12.18% -
Equity
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
Net Worth 194,744 192,761 179,444 172,829 159,457 167,817 160,519 13.79%
NOSH 99,869 100,396 99,691 50,095 49,986 49,945 50,006 58.78%
Ratio Analysis
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
NP Margin 6.51% 6.95% 6.38% 6.51% 5.92% 5.37% 5.67% -
ROE 19.97% 21.60% 20.81% 22.40% 21.50% 17.69% 19.19% -
Per Share
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
RPS 597.71 596.72 587.05 1,187.67 1,158.09 1,107.56 1,086.86 -32.94%
EPS 38.94 41.48 37.46 77.28 68.58 59.42 61.60 -26.40%
DPS 3.75 3.73 3.76 10.00 7.50 7.50 7.50 -37.08%
NAPS 1.95 1.92 1.80 3.45 3.19 3.36 3.21 -28.33%
Adjusted Per Share Value based on latest NOSH - 50,095
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
RPS 41.42 41.57 40.61 41.28 40.17 38.38 37.71 6.47%
EPS 2.70 2.89 2.59 2.69 2.38 2.06 2.14 16.81%
DPS 0.26 0.26 0.26 0.35 0.26 0.26 0.26 0.00%
NAPS 0.1351 0.1337 0.1245 0.1199 0.1106 0.1164 0.1114 13.76%
Price Multiplier on Financial Quarter End Date
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
Date 30/06/03 31/03/03 31/12/02 30/09/02 28/06/02 29/03/02 31/12/01 -
Price 4.07 3.64 3.80 7.68 7.32 7.32 7.27 -
P/RPS 0.68 0.61 0.65 0.65 0.63 0.66 0.67 0.99%
P/EPS 10.45 8.78 10.15 9.94 10.67 12.32 11.80 -7.80%
EY 9.57 11.40 9.86 10.06 9.37 8.12 8.47 8.50%
DY 0.92 1.02 0.99 1.30 1.02 1.02 1.03 -7.27%
P/NAPS 2.09 1.90 2.11 2.23 2.29 2.18 2.26 -5.09%
Price Multiplier on Announcement Date
30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 CAGR
Date 19/08/03 20/05/03 10/04/03 22/11/02 26/08/02 21/05/02 20/02/02 -
Price 4.73 3.69 3.62 7.36 7.86 7.86 6.77 -
P/RPS 0.79 0.62 0.62 0.62 0.68 0.71 0.62 17.58%
P/EPS 12.15 8.90 9.66 9.52 11.46 13.23 10.99 6.93%
EY 8.23 11.24 10.35 10.50 8.72 7.56 9.10 -6.49%
DY 0.79 1.01 1.04 1.36 0.95 0.95 1.11 -20.33%
P/NAPS 2.43 1.92 2.01 2.13 2.46 2.34 2.11 9.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment